| 注册
首页|期刊导航|中国药房|药源性横纹肌溶解症高危因素研究

药源性横纹肌溶解症高危因素研究

姜玲海 张军 方忠宏 周泉

中国药房Issue(29):4082-4085,4086,5.
中国药房Issue(29):4082-4085,4086,5.DOI:10.6039/j.issn.1001-0408.2015.29.17

药源性横纹肌溶解症高危因素研究

Causative Study of Drug-induced Rhabdomyolysis

姜玲海 1张军 1方忠宏 1周泉2

作者信息

  • 1. 复旦大学附属金山医院药剂科,上海 201508
  • 2. 上海市食品药品监督管理局金山分局,上海 200540
  • 折叠

摘要

Abstract

OBJECTIVE:To investigate and analyze the causative factors and characteristics of drug-induced rhabdomyolysis in China,in order to reduce the incidence of rhabdomyolysis. METHODS:Search all cases of rhabdomyolysis in China Knowledge Re-source Integrated Database from Jan 1975 to Jun 2014. Sex,age,disease history,drugs administered,drug combination,clinical presentation and outcome of rhabdomyolysis were censused and analyzed. RESULTS:There were altogether 185 rhabdomyolysis cas-es reported,of which 57.8% were over 60 years old ,78.9% were induced by lipid regulators,and 55.7% were by statins;74.1%occurred within 1 month after drug administration,and 86.6% became normal within 1 month when causative drugs discontinued or with treatment;and 4.9% died. CONCLUSIONS:Eldly,complicated with multi-factors,such as multiple organ dysfunction syn-drome,irrational drug combination and over-doses,especially with lipid regulators,are important causative factors of rhabdomyoly-sis. Individualized administration of drugs and prescription as less as possible should be recommended to reduce the incidence of rhabdomyolysis.

关键词

横纹肌溶解症/调节血脂药/他汀类药/多系统疾病

Key words

Rhabdomyolysis/Lipid regulators/Statins/Multiple organ dysfunction syndrome

分类

医药卫生

引用本文复制引用

姜玲海,张军,方忠宏,周泉..药源性横纹肌溶解症高危因素研究[J].中国药房,2015,(29):4082-4085,4086,5.

中国药房

OA北大核心CSTPCD

1001-0408

访问量0
|
下载量0
段落导航相关论文